SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-004886
Filing Date
2015-03-19
Accepted
2015-03-19 18:59:55
Documents
1
Period of Report
2015-03-17

Document Format Files

Seq Description Document Type Size
1 rrd423735.html 4  
1 rrd423735.xml 4 6153
  Complete submission text file 0001181431-15-004886.txt   7664
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Markvicka Taunia (Reporting) CIK: 0001545282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 15714111